Gout
Guidelines
EULAR CVD management guidance focuses on gout, lupus, vasculitis
The recommendations advise on managing cardiovascular health in patients with gout, vasculitis, systemic sclerosis, myositis, Sjögren syndrome,...
From the Journals
A range of healthy dietary patterns can reduce risk of gout in women
A study of four different healthy eating patterns in women found that all reduced the risk of new-onset gout in women, compared with a traditional...
From the Journals
Allopurinol found safe in patients with concomitant gout, CKD
Despite earlier concerns, a study has found no sign of increased mortality with allopurinol therapy in patients with gout and chronic kidney...
From the Journals
Super-low uric acid may not be best for erosive gout
Lowering the target for uric acid levels from the current standard doesn’t result in better gout outcomes and leads to more medication use and...
From the Journals
‘Misleading’ results in colchicine COVID-19 trials meta-analysis
Conference Coverage
Allopurinol proves noninferior to febuxostat for gout relief
A randomized, treat-to-target trial showed that the two urate-lowering therapies were comparably effective and safe at doses titrated to target,...
From the Journals
U.S. arthritis prevalence continues steady rise; activity limitations grow more rapidly
The latest survey data indicated that more Americans have arthritis than ever before, possibly because of an aging population, worsening...
Conference Coverage
Two swings, two misses with colchicine, Vascepa in COVID-19
The study cohorts varied from healthcare and public workers at high risk for infection to individuals already hospitalized with COVID-19.
Conference Coverage
Western and proinflammatory diets are important drivers of gout risk
Western and proinflammatory diets are associated with increased risk of gout independent of other factors.
From the Journals
Rheumatology clinics find success with smoking cessation referral program
Clinics that adopted a protocolized, EHR-based approach to checking for readiness to quit saw a 26-fold increase in quit-line referrals.
From the Journals
Febuxostat, allopurinol real-world cardiovascular risk appears equal
Medicare claims data from gout patients in 2008-2016 corroborate recent reports on febuxostat’s cardiovascular safety and all-cause mortality data...